What Is Atrial Fibrillation?

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterized by rapid and disorganized electrical activity in the atria of the heart, which overrides the normal sinus rhythm generated by the sinoatrial node. During AF, the atria contract irregularly and ineffectively at rates of 350 to 600 beats per minute rather than the normal 60 to 100 beats per minute, producing an irregularly irregular ventricular response. The condition affects an estimated 33 to 44 million individuals worldwide and is a leading cause of stroke, heart failure, and cardiovascular mortality. AF falls at the intersection of clinical cardiology, biomedical engineering, and signal processing, as its detection, classification, and treatment increasingly depend on computational and sensor technologies.

Electrophysiological Mechanisms

The underlying mechanisms of AF involve both focal trigger activity and the maintenance of multiple re-entrant wavefronts within the atrial myocardium. Pulmonary vein sleeves, thin extensions of atrial muscle that surround the pulmonary veins where they enter the left atrium, are the predominant source of ectopic electrical triggers in paroxysmal AF. Once AF is initiated, structural and electrical remodeling of the atrium, including fibrosis, ion channel downregulation, and shortening of the effective refractory period, creates conditions that sustain re-entrant circuits. Risk factors that promote this remodeling include hypertension, heart failure, advanced age, obesity, obstructive sleep apnea, and chronic alcohol use. As reviewed in Circulation: Arrhythmia and Electrophysiology, understanding the interaction between patient-specific anatomical structure and electrical wave propagation is central to explaining why some patients develop self-terminating paroxysmal episodes while others progress to persistent or permanent AF.

Diagnosis and ECG Detection

Atrial fibrillation is definitively diagnosed by the electrocardiogram (ECG), which shows the absence of distinct P-waves, an irregular baseline due to fibrillatory activity, and an irregularly irregular RR interval between QRS complexes. The PR interval and P-wave morphology are useful predictors of AF risk before overt arrhythmia develops. Standard 12-lead ECGs performed in clinical settings detect AF only if it is present during the recording window, which creates a challenge for paroxysmal AF that is brief and unpredictable. Continuous and ambulatory monitoring with Holter monitors, implantable loop recorders, and consumer wearable devices extends the detection window from 24 hours to months or years. As reported in a PMC study on early ECG-based AF detection, machine learning algorithms applied to single-lead ECG signals captured on smartwatches and handheld devices now achieve sensitivity and specificity comparable to clinical Holter interpretation.

Treatment Strategies

Treatment for AF is directed at two goals: controlling heart rate to prevent hemodynamic compromise, and reducing thromboembolic risk, particularly stroke, since the stagnant blood flow in the fibrillating atrium promotes clot formation in the left atrial appendage. Rate control is achieved pharmacologically with beta-blockers, calcium channel blockers, or digoxin. Rhythm control, restoring normal sinus rhythm, is pursued through electrical cardioversion or antiarrhythmic drugs including flecainide and amiodarone. Catheter ablation targets the pulmonary vein triggers by electrically isolating the pulmonary veins from the atrial body using radiofrequency energy or cryothermal ablation; success rates for paroxysmal AF at one year exceed 70 to 80 percent in experienced centers. Computational and AI-assisted models of atrial electrophysiology are being developed to guide patient-specific ablation planning and predict outcomes.

Applications

Atrial fibrillation research has applications in a range of fields, including:

• Wearable ECG sensors and mobile health platforms for population-scale screening
• Machine learning for automated arrhythmia classification and risk stratification
• Patient-specific cardiac digital twins for ablation procedure planning
• Implantable loop recorders for long-term rhythm surveillance
• Anticoagulation management guided by continuous rhythm monitoring data